Cet anticorps anti-VLDLR Monoclonal Lapin (Clone VLDLR-2896R) (ABIN7877497) détecte spécifiquement VLDLR dans ELISA.
L’anticorps est réactif avec des échantillons de Humain.
VLDLR
Reactivité: Humain, Souris
WB, FACS
Hôte: Lapin
Polyclonal
Cy5
Indications d'application
Optimal dilution of the recombinant VLDL Receptor antibody should be determined by the researcher.
Restrictions
For Research Use only
Format
Liquid
Concentration
0.2 mg/mL
Buffer
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store the recombinant VLDL Receptor antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Antigène
VLDLR
(Very Low Density Lipoprotein Receptor (VLDLR))
Autre désignation
VLDL Receptor
Sujet
VLDLR (very low density lipoprotein receptor) is a member of the LDL receptor gene family, which includes LDL receptor, LRP, megalin, VLDLR and ApoER2. The LDL receptor family is characterized by a cluster of cysteine-rich class A repeats, epidermal growth factor (EGF)-like repeats, YWTD repeats and an O-linked sugar domain. VLDLR associates with RAP (receptor associated protein) during receptor folding, and RAP facilitates the secretion of the extracellular region of VLDLR. VLDLR is thought to mediate the interaction of extracellular Reelin and cytosolic mDab1 (mammalian disabled protein), which activates a tyrosine kinase. This pathway regulates the migration of neurons along the radial glial fiber network during brain development.